Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Aquamin® as an Adjuvant Intervention for Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Aquamin as an adjuvant intervention for Ulcerative Colitis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aquamin

Snippet

Sponsor: Muhammad N Aslam, MD | Conditions: Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING